The FTC called out the nation’s leading pharmacy benefit managers for inflating pharmacy costs, affecting both employers and ...

In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus. Lantus cost $292 for a 30-day supply. Drugmaker Viatris launched two versions ...

The biggest pharmacy benefit managers have made efforts to improve relationships with pharmacies, health insurers, employers ...

The parents of Cole Schmidtknecht are suing Walgreens and OptumRx, a subsidiary of UnitedHealth Group, over the 22-year-old ...

The two have mended fences after a nasty contract dispute in 2022 caused Kroger pharmacies to go out of network with Express ...

“I’m proud that the FTC launched a bipartisan investigation into these shadowy middlemen, and its preliminary findings prove yet again that it’s time to bust up the PBM monopoly.” ...

The FTC's first report drew a strong response from the PBM sector, with lawsuits filed in both directions. The FTC has accused the big three of operating a "perverse drug rebate system," while the ...

Cole Schmidtknecht had chronic asthma since he was a child, and had used a steroid inhaler to control his symptoms for more ...

Wednesday, 92 independent, mom-pop pharmacies across the state will close their doors for a day of advocacy in Topeka. It’s a ...

The Odessa American is the leading source of local news, information, entertainment and sports for the Permian Basin.

The industry has come under scrutiny by the Federal Trade Commission. Its first report was released last year. It shows that PBMs profit at the expense of patients and independent pharmacies with ...

If California patients pay more than $35 per month for insulin now, it’s in large part because PBMs have rigged the system in ...